Relating to health benefit plan coverage for perimenopause and menopause medications.
Filed
Email me when HB 647 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 647. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
HB 647 would address how health benefit plans handle drugs used for perimenopause and menopause. It would affect women experiencing these life stages and the insurers that provide their coverage. The goal is to bring attention to potential gaps in access to these treatments.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 647
3 free questions a day, no accountSponsors
- Katrina Pierson (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 647 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 647 freeOr ask your AI assistant about HB 647 directly:
Add to Claude, ChatGPT or Cursor